United Therapeutics (UTHR) Tops Q1 EPS by 41c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $237.00 --0%
EPS Growth %: +19.1%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
UXIN, TOWN, NRIM, More
EPS Growth %: +19.1%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $2.55, $0.41 better than the analyst estimate of $2.14. Revenue for the quarter came in at $327.6 million versus the consensus estimate of $353.5 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- STMicroelectronics cuts outlook as slower demand causes Q1 miss
- Ford (F) earnings top estimates in Q1 amid strength in Pro unit; stock up
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
